文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

休克管理中未处理的相对低血压(以灌注压差衡量)与新发急性肾损伤:文献综述

Untreated Relative Hypotension Measured as Perfusion Pressure Deficit During Management of Shock and New-Onset Acute Kidney Injury-A Literature Review.
PubMed 文献 · Shock · 2018-01-01
一句话结论综述指出,实践中常统一追求血压目标而无意中接受相对低血压(患者病前基础血压与达成血压之差),后者与休克患者新发器官功能障碍或急性肾损伤显著相关,但证据质量不高。

该综述探讨休克管理中相对低血压(即患者病前基础血压与血管升压药支持下达成血压之间的差值,以灌注压差衡量)的病理生理机制,重点关注其与新发急性肾损伤(AKI)风险的关系。检索Medline、Embase和Google Scholar,纳入基于患者病前血压调整血压目标或以相对低血压为暴露终点并评估其与急性病患者临床结局关联的研究。未发现随机对照试验,仅识别出7项研究并详细综述。这些研究提示,真实世界实践中无意接受的相对低血压程度与新发器官功能障碍或后续AKI显著相关,但证据质量不高;需要设计良好的随机对照试验评估个体化血压目标(初始由患者病前基础血压引导,再根据临床反应调整)是否优于常规血管升压药治疗血压目标,尤其是在血管扩张性休克患者中。

要点

  • 相对低血压指患者病前基础血压与血管升压药支持下达成血压之间的差值,临床中常被忽视且未处理。
  • 综述识别出7项研究,均非随机对照试验,提示真实世界中无意接受的相对低血压程度与新发器官功能障碍或后续AKI显著相关。
  • 从生理角度,器官(如肾脏)血管床净灌注压的任何相对降低都可能压倒休克时已承受压力的自身调节机制。
  • 作者认为需要设计良好的随机对照试验评估个体化血压目标(初始由病前基础血压引导、再根据临床反应调整)是否优于常规血管升压药治疗血压目标,尤其在血管扩张性休克患者中。

适用人群与场景

  • 急性病患者,包括潜在休克状态的患者;研究涉及接受血管升压药治疗的患者。
  • 血管扩张性休克患者被作者特别提及为未来随机对照试验应重点评估的人群。

红旗征与不能漏的情况

  • 相对低血压是常见但未被充分认识且未充分治疗的表现,存在于潜在休克状态患者中。

研究设计与关键结果

  • 综述检索Medline、Embase和Google Scholar,纳入基于患者病前血压调整血压目标或以相对低血压为暴露终点并评估其与急性病患者临床结局关联的研究;未发现随机对照试验,仅识别出7项研究并详细综述。
  • 这些研究提示,真实世界实践中无意接受的相对低血压程度与新发器官功能障碍或后续AKI显著相关。
  • 作者指出这不是高质量证据。

证据类型、等级与局限

  • 文献综述,纳入7项非随机对照试验的研究。
  • 作者指出这不是高质量证据。
  • 局限:未发现随机对照试验;仅识别出7项研究;作者指出这不是高质量证据。

对床旁实践的改变

  • 作者认为需要设计良好的随机对照试验评估个体化血压目标(初始由患者病前基础血压引导,再根据临床反应调整)是否优于常规血管升压药治疗血压目标,尤其在血管扩张性休克患者中。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Maintaining an optimal blood pressure (BP) during shock is a fundamental tenet of critical care. Optimal BP targets may be different for different patients. In current practice, too often, uniform BP targets are pursued which may result in inadvertently accepting a degree of untreated relative hypotension, i.e., the deficit between patients' usual premorbid basal BP and the achieved BP, during vasopressor support. Relative hypotension is a common but an under-recognized and an under-treated sign among patients with potential shock state. From a physiological perspective, any relative reduction in the net perfusion pressure across an organ (e.g., renal) vasculature has a potential to overwhelm autoregulatory mechanisms, which are already under stress during shock. Such perfusion pressure deficit may consequently impact organs' ability to function or recover from an injured state. This review discusses such pathophysiologic mechanisms in detail with a particular focus on the risk of new-onset acute kidney injury (AKI). To review current literature, databases of Medline, Embase, and Google scholar were searched to retrieve articles that either adjusted BP targets based on patients' premorbid BP levels or considered relative hypotension as an exposure endpoint and assessed its association with clinical outcomes among acutely ill patients. There were no randomized controlled trials. Only seven studies could be identified and these were reviewed in detail. These studies indicated a significant association between the degree of relative hypotension that was inadvertently accepted in real-world practice and new-onset organ dysfunction or subsequent AKI. However, this is not a high-quality evidence. Therefore, well-designed randomized controlled trials are needed to evaluate whether adoption of individualized BP targets, which are initially guided by patient's premorbid basal BP and then tailored according to clinical response, is superior to conventional BP targets for vasopressor therapy, particularly among patients with vasodilatory shock states.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Panwar R. Untreated Relative Hypotension Measured as Perfusion Pressure Deficit During Management of Shock and New-Onset Acute Kidney Injury-A Literature Review. Shock. 2018. PMID: 29040214. doi:10.1097/SHK.0000000000001033

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。